Lenvatinib-Induced Acute Pancreatitis in a Patient with Metastatic Thyroid Cancer: A Case Report.
Hong Jun KimJae Joon HanChi Hoon MaengSun Kyung BaekPublished in: International journal of general medicine (2020)
Physicians should consider acute pancreatitis as a differential diagnosis for patients complaining of abdominal pain while on lenvatinib, regardless of hyperamylasemia or hyperlipasemia. Systematic collection of data on acute pancreatitis development during lenvatinib treatment should be considered, and further research is warranted to identify the mechanism of acute pancreatitis associated with multi-target tyrosine kinase inhibitors such as lenvatinib.
Keyphrases
- abdominal pain
- end stage renal disease
- ejection fraction
- primary care
- squamous cell carcinoma
- chronic kidney disease
- newly diagnosed
- small cell lung cancer
- peritoneal dialysis
- prognostic factors
- big data
- diabetic rats
- patient reported outcomes
- replacement therapy
- data analysis
- patient reported
- chronic myeloid leukemia
- smoking cessation